18th Annual John Goldman Conference on CML: Biology and Therapy

18th Annual John Goldman Conference on CML: Biology and Therapy

Join us in Houston, TX for the 18th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy.

Speakers at this meeting will present the newest and often unpublished data that relate to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) Aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells and approaches to cure.

Back To
Top